Publications
Articles
Changes in T-cell subsets identify responders to FcR non-binding anti-CD3 mAb (teplizumab) in patients with Type 1 diabetes
(2016). Eur J Immunol, 46 (1), 230-41. http://dx.doi.org/10.1002/eji.201545708, PMID: 26518356, PMCID: PMC4882099
Tooley JE, Vudattu N, Choi J, Cotsapas C, Devine L, Raddassi K, Ehlers MR, Harris KM, Kanaparthi S, Phippard D, Herold KC, McNamara JG
[Reprint] [PubMed]
[Citation View]
Tooley JE, Vudattu N, Choi J, Cotsapas C, Devine L, Raddassi K, Ehlers MR, Harris KM, Kanaparthi S, Phippard D, Herold KC, McNamara JG (2016). Changes in T-cell subsets identify responders to FcR non-binding anti-CD3 mAb (teplizumab) in patients with Type 1 diabetes. Eur J Immunol, 46 (1), 230-41.
Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection
(2016). Eur J Neurol, 23 (2), 327-32. http://dx.doi.org/10.1111/ene.12844, PMID: 26518224
Pelletier D, Gao Z, Zamvil SS, Waubant E, Mowry EM, Howell MD
[Reprint] [PubMed]
[Citation View]
Pelletier D, Gao Z, Zamvil SS, Waubant E, Mowry EM, Howell MD (2016). Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection. Eur J Neurol, 23 (2), 327-32.
Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3
(2016). Arthritis Rheumatol, 68 (7), 1700-10. http://dx.doi.org/10.1002/art.39637, PMID: 26882078
Hummel AM, Cartin-ceba R, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Tchao NK, Stone JH, Fussner LA, Schroeder DR, Silva F, Snyder MR, Specks U; RAVE-ITN Research Group.
[Reprint] [PubMed]
[Citation View]
Hummel AM, Cartin-ceba R, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Tchao NK, Stone JH, Fussner LA, Schroeder DR, Silva F, Snyder MR, Specks U; RAVE-ITN Research Group. (2016). Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3. Arthritis Rheumatol, 68 (7), 1700-10.
A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice
(2016). Diabetes, 65 (5), 1310-16. http://dx.doi.org/10.2337/db15-0492, PMID: 26718498
Gill RG, Pagni PP, Posgai A, Manenkova Y, Straub L, Bernstein P, Herold KC, von Herrath M, Staeva T, Ehlers MR, Nepom GT, Kufper T, Wasserfall CH, Deng S, Hani AB, Atkinson MA
[Reprint] [PubMed]
[Citation View]
Gill RG, Pagni PP, Posgai A, Manenkova Y, Straub L, Bernstein P, Herold KC, von Herrath M, Staeva T, Ehlers MR, Nepom GT, Kufper T, Wasserfall CH, Deng S, Hani AB, Atkinson MA (2016). A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice. Diabetes, 65 (5), 1310-16.
Effect of Avoidance on Peanut Allergy after Early Peanut Consumption
(2016). N Engl J Med, 14 (374), 1435-43. http://dx.doi.org/10.1056/NEJMoa1514209, PMID: 26942922
Du Toit G, Sayre PH, Roberts G, Sever ML, Lawson K, Bahnson HT, Brough HA, Santos AF, Harris KM, Radulovic S, Basting M, Turcanu V, Plaut M, Lack G; Immune Tolerance Network LEAP-On Study Team
[Reprint] [PubMed]
[Citation View]
Du Toit G, Sayre PH, Roberts G, Sever ML, Lawson K, Bahnson HT, Brough HA, Santos AF, Harris KM, Radulovic S, Basting M, Turcanu V, Plaut M, Lack G; Immune Tolerance Network LEAP-On Study Team (2016). Effect of Avoidance on Peanut Allergy after Early Peanut Consumption. N Engl J Med, 14 (374), 1435-43.
Two- and Four-Hour Tests Differ in Capture of C-Peptide Responses to a Mixed Meal in Type 1 Diabetes
(2016). Diabetes Care, 39 (6), e76-8. http://dx.doi.org/10.2337/dc15-2077, PMID: 27208317, PMCID: PMC4878222
Boyle KD, Keyes-Elstein L, Ehlers MR, McNamara J, Rigby MR, Gitelman SE, Herold KC, Weiner LJ, Much KL
[Reprint] [PubMed]
[Citation View]
Boyle KD, Keyes-Elstein L, Ehlers MR, McNamara J, Rigby MR, Gitelman SE, Herold KC, Weiner LJ, Much KL (2016). Two- and Four-Hour Tests Differ in Capture of C-Peptide Responses to a Mixed Meal in Type 1 Diabetes. Diabetes Care, 39 (6), e76-8.
Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial
(2016). Diabetologia, 59 (6), 1153-61. http://dx.doi.org/10.1007/s00125-016-3917-4, PMID: 27053235, PMCID: PMC4869699
Gitelman SE, Gottlieb PA, Felner EI, Willi SM, Fisher LK, Moran A, Gottschalk M, Moore WV, Pinckney A, Keyes-Elstein L, Harris KM, Kanaparthi S, Phippard D, Ding L, Bluestone JA, Ehlers MR; ITN START Study Team
[Reprint] [PubMed]
[Citation View]
Gitelman SE, Gottlieb PA, Felner EI, Willi SM, Fisher LK, Moran A, Gottschalk M, Moore WV, Pinckney A, Keyes-Elstein L, Harris KM, Kanaparthi S, Phippard D, Ding L, Bluestone JA, Ehlers MR; ITN START Study Team (2016). Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial. Diabetologia, 59 (6), 1153-61.
Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial
(2016). Clin Ther, 38 (6), 1327-39. http://dx.doi.org/10.1016/j.clinthera.2016.04.032, PMID: 27209482, PMCID: PMC4916002
Pinckney A, Rigby MR, Keyes-Elstein L, Soppe CL, Nepom GT, Ehlers MR
[Reprint] [PubMed]
[Citation View]
Pinckney A, Rigby MR, Keyes-Elstein L, Soppe CL, Nepom GT, Ehlers MR (2016). Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial. Clin Ther, 38 (6), 1327-39.
Impact of peanut consumption in the LEAP Study: Feasibility, growth, and nutrition
(2016). J Allergy Clin Immunol, pii: S0091-6749 (16), 30262-7. http://dx.doi.org/10.1016/j.jaci.2016.04.016, PMID: 27297994, PMCID: PMC5056823
Feeney M, Du Toit G, Roberts G, Sayre PH, Lawson K, Bahnson HT, Sever ML, Radulovic S, Plaut M, Lack G, Immune Tolerance Network LEAP Study Team
[Reprint] [PubMed]
[Citation View]
Feeney M, Du Toit G, Roberts G, Sayre PH, Lawson K, Bahnson HT, Sever ML, Radulovic S, Plaut M, Lack G, Immune Tolerance Network LEAP Study Team (2016). Impact of peanut consumption in the LEAP Study: Feasibility, growth, and nutrition . J Allergy Clin Immunol, pii: S0091-6749 (16), 30262-7.
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
(2016). Cytotherapy, 18 (2), 151-9. http://dx.doi.org/10.1016/j.jcyt.2015.11.008, PMID: 26724220, PMCID: PMC4745114
Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, Hematti P, Koh MB, LeBlanc K, Martin I, McNiece IK, Mendicino M, Oh S, Ortiz L, Phinney DG, Planat V, Shi Y, Stroncek DF, Viswanathan S, Weiss DJ, Sensebe L
[Reprint] [PubMed]
[Citation View]
Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, Hematti P, Koh MB, LeBlanc K, Martin I, McNiece IK, Mendicino M, Oh S, Ortiz L, Phinney DG, Planat V, Shi Y, Stroncek DF, Viswanathan S, Weiss DJ, Sensebe L (2016). International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy, 18 (2), 151-9.
Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes
(2016). Science Immunology, 1 (5), pii: eaai7793. http://dx.doi.org/10.1126/sciimmunol.aai7793, PMID: 28664195, PMCID: PMC5486405
Long SA, Harris KM, Ehlers M, Herold KC, Nepom GT, Jerill Thorpe J, DeBerg HA, Gersuk V, Eddy JA, Linsley PS
[Reprint] [PubMed]
[Citation View]
Long SA, Harris KM, Ehlers M, Herold KC, Nepom GT, Jerill Thorpe J, DeBerg HA, Gersuk V, Eddy JA, Linsley PS (2016). Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes. Science Immunology, 1 (5), pii: eaai7793.
A role for plasma cell targeting agents in immune tolerance induction in autoimmune disease and antibody responses to therapeutic proteins
(2016). Clin Immunol, 165 (April 2016), 55-9. http://dx.doi.org/10.1016/j.clim.2016.02.009, PMID: 26928739
Diamond B, Turka LA, Rosenberg AS, Pariser AR, Yao L, Lacana E, Kishnani PS
[Reprint] [PubMed]
[Citation View]
Diamond B, Turka LA, Rosenberg AS, Pariser AR, Yao L, Lacana E, Kishnani PS (2016). A role for plasma cell targeting agents in immune tolerance induction in autoimmune disease and antibody responses to therapeutic proteins. Clin Immunol, 165 (April 2016), 55-9.
Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers
(2016). Am J Transplant, 16 (1), 221-34. http://dx.doi.org/10.1111/ajt.13416, PMID: 26227106, PMCID: PMC4718825
Mathew JM, Levitsky J, Miller J, Leventhal JR, Salomon DR, Kurian SM, Friedewald JJ, Gallon L, Konieczna I, Tambur AR, Charette J, Jie C, Kanwar YS, Abecassis MM
[Reprint] [PubMed]
[Citation View]
Mathew JM, Levitsky J, Miller J, Leventhal JR, Salomon DR, Kurian SM, Friedewald JJ, Gallon L, Konieczna I, Tambur AR, Charette J, Jie C, Kanwar YS, Abecassis MM (2016). Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers. Am J Transplant, 16 (1), 221-34.
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets
(2016). Arthritis Rheumatol, 68 (12), 2945-52. http://dx.doi.org/10.1002/art.39812, PMID: 27428559, PMCID: PMC5541999
Miloslavsky EM, Lu N, Unizony S, Choi HK, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Fervenza F, Monach PA, Specks U, Stone JH
[Reprint] [PubMed]
[Citation View]
Miloslavsky EM, Lu N, Unizony S, Choi HK, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Fervenza F, Monach PA, Specks U, Stone JH (2016). Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets. Arthritis Rheumatol, 68 (12), 2945-52.
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): A 3-year interim report
(2015). JAMA Neurology, 72 (2), 159-69. http://dx.doi.org/10.1001/jamaneurol.2014.3780, PMID: 25546364, PMCID: PMC5261862
Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stüve O, Arnold DL, Spychala ME, McConville KC, Harris KM, Phippard D, Georges GE, Wundes A, Kraft GH, Bowen JD
[Reprint] [PubMed]
[Citation View]
Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stüve O, Arnold DL, Spychala ME, McConville KC, Harris KM, Phippard D, Georges GE, Wundes A, Kraft GH, Bowen JD (2015). High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): A 3-year interim report. JAMA Neurology, 72 (2), 159-69.
Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients
(2015). Sci Transl Med, 7 (272), 272ra10. http://dx.doi.org/10.1126/scitranslmed.3010760, PMID: 25632034, PMCID: PMC4360892
Morris H, DeWolf S, Robins H, Sprangers B, LoCascio SA, Shonts BA, Kawai T, Wong W, Yang S, Zuber J, Shen Y, Sykes M
[Reprint] [PubMed]
[Citation View]
Morris H, DeWolf S, Robins H, Sprangers B, LoCascio SA, Shonts BA, Kawai T, Wong W, Yang S, Zuber J, Shen Y, Sykes M (2015). Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients. Sci Transl Med, 7 (272), 272ra10.
Randomized trial of peanut consumption in infants at risk for peanut allergy
(2015). N Engl J Med, 372 (9), 803-813. http://dx.doi.org/10.1056/NEJMoa1414850, PMID: 25705822, PMCID: PMC4416404
Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, Brough HA, Phippard D, Basting M, Feeney M, Turcanu V, Sever ML, Gomez Lorenzo M, Plaut M, Lack G; LEAP Study Team
[Reprint] [PubMed]
[Citation View]
Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, Brough HA, Phippard D, Basting M, Feeney M, Turcanu V, Sever ML, Gomez Lorenzo M, Plaut M, Lack G; LEAP Study Team (2015). Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med, 372 (9), 803-813.
Peripheral CD5+ B-cells in antineutrophil cytoplasmic antibody-associated vasculitis
(2015). Arthritis Rheumatol, 67 (2), 535-44. http://dx.doi.org/10.1002/art.38916, PMID: 25332071, PMCID: PMC4497572
Unizony S, Lim N, Phippard DJ, Carey VJ, Miloslavsky EM, Tchao NK, Ikle D, Asare AL, Merkel PA, Monach PA, Seo P, St Clair EW, Langford CA, Spiera R, Hoffman GS, Kallenberg CG, Specks U, Stone JH.
[Reprint] [PubMed]
[Citation View]
Unizony S, Lim N, Phippard DJ, Carey VJ, Miloslavsky EM, Tchao NK, Ikle D, Asare AL, Merkel PA, Monach PA, Seo P, St Clair EW, Langford CA, Spiera R, Hoffman GS, Kallenberg CG, Specks U, Stone JH. (2015). Peripheral CD5+ B-cells in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol, 67 (2), 535-44.
Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individuals
(2015). Allergy, 70 (2), 171-9. http://dx.doi.org/10.1111/all.12543, PMID: 25377909
Shamji MH, Bellido V, Scadding GW, Layhadi JA, Cheung DK, Calderon MA, Asare A, Gao Z, Turka LA, Tchao N, Togias A, Phippard D, Durham SR.
[Reprint] [PubMed]
[Citation View]
Shamji MH, Bellido V, Scadding GW, Layhadi JA, Cheung DK, Calderon MA, Asare A, Gao Z, Turka LA, Tchao N, Togias A, Phippard D, Durham SR. (2015). Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individuals. Allergy, 70 (2), 171-9.
Basophil expression of diamine oxidase: a novel biomarker of allergen immunotherapy response
(2015). J Allergy Clin Immunol, 135 (4), 913-21. http://dx.doi.org/10.1016/j.jaci.2014.09.049, PMID: 25457150
Shamji MH, Layhadi JA, Scadding GW, Cheung DK, Calderon MA, Turka LA, Phippard D, Durham SR
[Reprint] [PubMed]
[Citation View]
Shamji MH, Layhadi JA, Scadding GW, Cheung DK, Calderon MA, Turka LA, Phippard D, Durham SR (2015). Basophil expression of diamine oxidase: a novel biomarker of allergen immunotherapy response. J Allergy Clin Immunol, 135 (4), 913-21.
Local and systemic effects of cat allergen nasal provocation
(2015). Clin Exp Allergy, 45 (3), 613-23. http://dx.doi.org/10.1111/cea.12434, PMID: 25303516, PMCID: PMC4778413
Scadding GW, Eifan A, Penagos M, Dumitru A, Switzer A, McMahon O, Phippard D, Togias A, Durham SR, Shamji MH
[Reprint] [PubMed]
[Citation View]
Scadding GW, Eifan A, Penagos M, Dumitru A, Switzer A, McMahon O, Phippard D, Togias A, Durham SR, Shamji MH (2015). Local and systemic effects of cat allergen nasal provocation. Clin Exp Allergy, 45 (3), 613-23.
An interactive web application for the dissemination of human systems immunology data
(2015). J Transl Med, 19 (13), 196. http://dx.doi.org/10.1186/s12967-015-0541-x, PMID: 26088622, PMCID: PMC4474328
Speake C, Presnell S, Domico K, Zeitner B, Bjork A, Anderson D, Mason MJ, Whalen E, Vargas O, Popov D, Rinchai D, Jourde-Chiche N, Chiche L, Quinn C, Chaussabel D
[Reprint] [PubMed]
[Citation View]
Speake C, Presnell S, Domico K, Zeitner B, Bjork A, Anderson D, Mason MJ, Whalen E, Vargas O, Popov D, Rinchai D, Jourde-Chiche N, Chiche L, Quinn C, Chaussabel D (2015). An interactive web application for the dissemination of human systems immunology data. J Transl Med, 19 (13), 196.
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
(2015). J Clin Invest, 125 (8), 3285-96. http://dx.doi.org/10.1172/JCI81722, PMID: 26193635, PMCID: PMC4623571
Mark R. Rigby, Kristina M. Harris, Ashley Pinckney, Linda A. DiMeglio, Marc S. Rendell, Eric I. Felner, Jean M. Dostou, Stephen E. Gitelman, Kurt J. Griffin, Eva Tsalikian, Peter A. Gottlieb, Carla J. Greenbaum, Nicole A. Sherry, Wayne V. Moore, Roshanak Monzavi, Steven M. Willi, Philip Raskin, Lynette Keyes-Elstein, S. Alice Long, Sai Kanaparthi, Noha Lim, Deborah Phippard, Carol L. Soppe, Margret L. Fitzgibbon, James McNamara, Gerald T. Nepom, Mario R. Ehlers, Immune Tolerance Network T1DAL Study Group
[Reprint] [PubMed]
[Citation View]
Mark R. Rigby, Kristina M. Harris, Ashley Pinckney, Linda A. DiMeglio, Marc S. Rendell, Eric I. Felner, Jean M. Dostou, Stephen E. Gitelman, Kurt J. Griffin, Eva Tsalikian, Peter A. Gottlieb, Carla J. Greenbaum, Nicole A. Sherry, Wayne V. Moore, Roshanak Monzavi, Steven M. Willi, Philip Raskin, Lynette Keyes-Elstein, S. Alice Long, Sai Kanaparthi, Noha Lim, Deborah Phippard, Carol L. Soppe, Margret L. Fitzgibbon, James McNamara, Gerald T. Nepom, Mario R. Ehlers, Immune Tolerance Network T1DAL Study Group (2015). Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients. J Clin Invest, 125 (8), 3285-96.
Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
(2015). Arthritis Rheumatol, 67 (7), 1922-32. http://dx.doi.org/10.1002/art.39153, PMID: 25891759, PMCID: PMC4485551
Grayson PC, Carmona-Rivera C, Xu L, Lim N, Gao Z, Asare AL, Specks U, Stone JH, Seo P, Spiera RF, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Ytterberg SR, Phippard DJ, Merkel PA, Kaplan MJ, Monach PA; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group
[Reprint] [PubMed]
[Citation View]
Grayson PC, Carmona-Rivera C, Xu L, Lim N, Gao Z, Asare AL, Specks U, Stone JH, Seo P, Spiera RF, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Ytterberg SR, Phippard DJ, Merkel PA, Kaplan MJ, Monach PA; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group (2015). Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol, 67 (7), 1922-32.
Longitudinal Studies of a B Cell-Derived Signature of Tolerance in Renal Transplant Recipients
(2015). Am J Transplant, 15 (11), 2908-20. http://dx.doi.org/10.1111/ajt.13480, PMID: 26461968, PMCID: PMC4725587
Newell KA, Asare A, Sanz I, Wei C, Rosenberg A, Gao Z, Kanaparthi S, Asare S, Lim N, Stahly M, Howell M, Knechtle S, Kirk A, Marks WH, Kawai T, Spitzer T, Tolkoff-Rubin N, Sykes M, Sachs DH, Cosimi AB, Burlingham WJ, Phippard D, Turka LA
[Reprint] [PubMed]
[Citation View]
Newell KA, Asare A, Sanz I, Wei C, Rosenberg A, Gao Z, Kanaparthi S, Asare S, Lim N, Stahly M, Howell M, Knechtle S, Kirk A, Marks WH, Kawai T, Spitzer T, Tolkoff-Rubin N, Sykes M, Sachs DH, Cosimi AB, Burlingham WJ, Phippard D, Turka LA (2015). Longitudinal Studies of a B Cell-Derived Signature of Tolerance in Renal Transplant Recipients. Am J Transplant, 15 (11), 2908-20.
Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids
(2015). Arthritis Rheumatol, 67 (6), 1629-36. http://dx.doi.org/10.1002/art.39104, PMID: 25776953
Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Ding L, Ikle D, Villareal M, Lim N, Brunetta P, Fervenza FC, Monach PA, Stone JH; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group.
[Reprint] [PubMed]
[Citation View]
Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Ding L, Ikle D, Villareal M, Lim N, Brunetta P, Fervenza FC, Monach PA, Stone JH; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group. (2015). Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids. Arthritis Rheumatol, 67 (6), 1629-36.
Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement
(2015). J Am Soc Nephrol, 26 (4), 796-85. http://dx.doi.org/10.1681/ASN.2014010046, PMID: 25381429, PMCID: PMC4378104
Geetha D, Specks U, Stone JH, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Tchao NK, Ikle D, Jepson B, Brunetta P, Fervenza FC; Rituximab for ANCA-Associated Vasculitis Immune Tolerance Network Research Group.
[Reprint] [PubMed]
[Citation View]
Geetha D, Specks U, Stone JH, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Tchao NK, Ikle D, Jepson B, Brunetta P, Fervenza FC; Rituximab for ANCA-Associated Vasculitis Immune Tolerance Network Research Group. (2015). Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement. J Am Soc Nephrol, 26 (4), 796-85.
Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial
(2015). J Allergy Clin Immunol, 135 (5), 1240-8. http://dx.doi.org/10.1016/j.jaci.2014.12.1917, PMID: 25656999, PMCID: PMC4527157
Burks AW, Wood RA, Jones SM, Scurlock AM, Vickery BP, Liu AH, Lindblad R, Plaut M, Sicherer SH, Fleischer DM, Henning AK, Dawson P, Sampson HA; Consortium of Food Allergy Research.
[Reprint] [PubMed]
[Citation View]
Burks AW, Wood RA, Jones SM, Scurlock AM, Vickery BP, Liu AH, Lindblad R, Plaut M, Sicherer SH, Fleischer DM, Henning AK, Dawson P, Sampson HA; Consortium of Food Allergy Research. (2015). Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial. J Allergy Clin Immunol, 135 (5), 1240-8.
Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge
(2015). Allergy, 70 (6), 689-96. http://dx.doi.org/10.1111/all.12608, PMID: 25773990, PMCID: PMC4826905
Scadding GW, Penagos M, Switzer A, Phippard D, Togias A, Shamji MH, Durham SR, Eifan AO, Lao-Araya M, Poon SY, Steveling E, Yan R
[Reprint] [PubMed]
[Citation View]
Scadding GW, Penagos M, Switzer A, Phippard D, Togias A, Shamji MH, Durham SR, Eifan AO, Lao-Araya M, Poon SY, Steveling E, Yan R (2015). Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge. Allergy, 70 (6), 689-96.
Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation
(2015). Biomark Insights, 10 (Suppl 4), 19-24. http://dx.doi.org/10.4137/BMI.S29697, PMID: 26462120, PMCID: PMC4589091
Speake C, Odegard JM
[Reprint] [PubMed]
[Citation View]
Speake C, Odegard JM (2015). Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation. Biomark Insights, 10 (Suppl 4), 19-24.
HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide
(2015). Bone Marrow Transplant, 50 (Suppl 2), S31-6. http://dx.doi.org/10.1038/bmt.2015.92, PMID: 26039204, PMCID: PMC4634886
Fuchs EJ
[Reprint] [PubMed]
[Citation View]
Fuchs EJ (2015). HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide. Bone Marrow Transplant, 50 (Suppl 2), S31-6.
Posttransplant Metabolic Syndrome in the Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients (WISP-R) Pilot Trial
(2015). Am J Transplant, 15 (3), 779-85. http://dx.doi.org/10.1111/ajt.13024, PMID: 25648649, PMCID: PMC4426259
Rosenthal P, Alonso EM, Ekong UD, Lobritto SJ, Feng S, Perito ER, Mohammad S
[Reprint] [PubMed]
[Citation View]
Rosenthal P, Alonso EM, Ekong UD, Lobritto SJ, Feng S, Perito ER, Mohammad S (2015). Posttransplant Metabolic Syndrome in the Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients (WISP-R) Pilot Trial. Am J Transplant, 15 (3), 779-85.
Concept and design of a genome-wide association genotyping array tailored for transplantation-specific studies
(2015). Genome Med, 7 (1), 90. http://dx.doi.org/10.1186/s13073-015-0211-x., PMID: 26423053, PMCID: PMC4589899
Li YR, van Setten J, Verma SS, Lu Y, Holmes MV, Gao H, Lek M, Nair N, Chandrupatla H, Chang B, Karczewski KJ, Wong C, Mohebnasab M, Mukhtar E, Phillips R, Tragante V, Hou C, Steel L, Lee T, Garifallou J, Guettouche T, Cao H, Guan W, Himes A, van Houten J, Pasquier A, Yu R, Carrigan E, Miller MB, Schladt D, Akdere A, Gonzalez A, Llyod KM, McGinn D, Michaud Z, Colasacco A, Snyder J, Thomas K, Wang T, Wu B, Alzahrani AJ, Al-Ali AK, Al-Muhanna FA, Al-Rubaish AM, Al-Mueilo S, Monos DS, Murphy B, Olthoff KM, Wijmenga C, Webster T, Kamoun M, Balasubramanian S, Lanktree MB, Oetting WS, Garcia-Pavia P, MacArthur DG, Hakonarson H, Birdwell KA, Jacobson PA, Ritchie MD, Asselbergs FW, Israni AK, Shaked A, Keating BJ, Gangasan Ai, de Bakker PIW
[Reprint] [PubMed]
[Citation View]
Li YR, van Setten J, Verma SS, Lu Y, Holmes MV, Gao H, Lek M, Nair N, Chandrupatla H, Chang B, Karczewski KJ, Wong C, Mohebnasab M, Mukhtar E, Phillips R, Tragante V, Hou C, Steel L, Lee T, Garifallou J, Guettouche T, Cao H, Guan W, Himes A, van Houten J, Pasquier A, Yu R, Carrigan E, Miller MB, Schladt D, Akdere A, Gonzalez A, Llyod KM, McGinn D, Michaud Z, Colasacco A, Snyder J, Thomas K, Wang T, Wu B, Alzahrani AJ, Al-Ali AK, Al-Muhanna FA, Al-Rubaish AM, Al-Mueilo S, Monos DS, Murphy B, Olthoff KM, Wijmenga C, Webster T, Kamoun M, Balasubramanian S, Lanktree MB, Oetting WS, Garcia-Pavia P, MacArthur DG, Hakonarson H, Birdwell KA, Jacobson PA, Ritchie MD, Asselbergs FW, Israni AK, Shaked A, Keating BJ, Gangasan Ai, de Bakker PIW (2015). Concept and design of a genome-wide association genotyping array tailored for transplantation-specific studies. Genome Med, 7 (1), 90.
Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II Multimers
(2015). J Immunol, 195 (12), 5827-36. http://dx.doi.org/10.4049/jimmunol.1402787, PMID: 26553072, PMCID: PMC4671089
Holland CJ, Dolton G, Scurr M, Ladell K, Schauenburg AJ, Miners K, Madura F, Sewell AK, Price DA, Cole DK, Godkin AJ
[Reprint] [PubMed]
[Citation View]
Holland CJ, Dolton G, Scurr M, Ladell K, Schauenburg AJ, Miners K, Madura F, Sewell AK, Price DA, Cole DK, Godkin AJ (2015). Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II Multimers. J Immunol, 195 (12), 5827-36.
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
(2015). J Autoimmun, Apr (58), 48-58. http://dx.doi.org/10.1016/j.jaut.2015.01.001, PMID: 25634360
Rosenzwajg M, Churlaud G, Mallone R, Six A, Dérian N, Chaara W, Lorenzon R, Long SA, Buckner JH, Afonso G, Pham HP, Hartemann A, Yu A, Pugliese A, Malek TR, Klatzmann D
[Reprint] [PubMed]
[Citation View]
Rosenzwajg M, Churlaud G, Mallone R, Six A, Dérian N, Chaara W, Lorenzon R, Long SA, Buckner JH, Afonso G, Pham HP, Hartemann A, Yu A, Pugliese A, Malek TR, Klatzmann D (2015). Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients. J Autoimmun, Apr (58), 48-58.
Design and Implementation of the International Genetics and Translational Research in Transplantation Network
(2015). Transplantation, 99 (11), 2401-12. http://dx.doi.org/10.1097/TP.0000000000000913, PMID: 26479416, PMCID: PMC4623847
International Genetics & Translational Research in Transplantation Network (iGeneTRAiN)
[Reprint] [PubMed]
[Citation View]
International Genetics & Translational Research in Transplantation Network (iGeneTRAiN) (2015). Design and Implementation of the International Genetics and Translational Research in Transplantation Network. Transplantation, 99 (11), 2401-12.
Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations
(2015). J Allergy Clin Immunol, 136 (6), 1476-85. http://dx.doi.org/10.1016/j.jaci.2015.09.008, PMID: 26518090, PMCID: PMC4679705
Teach SJ, Gill MA, Togias A, Sorkness CA, Arbes SJ Jr, Calatroni A, Wildfire JJ, Gergen PJ, Cohen RT, Pongracic JA, Kercsmar CM, Khurana Hershey GK, Gruchalla RS, Liu AH, Zoratti EM, Kattan M, Grindle KA, Gern JE, Busse WW, Szefler SJ1
[Reprint] [PubMed]
[Citation View]
Teach SJ, Gill MA, Togias A, Sorkness CA, Arbes SJ Jr, Calatroni A, Wildfire JJ, Gergen PJ, Cohen RT, Pongracic JA, Kercsmar CM, Khurana Hershey GK, Gruchalla RS, Liu AH, Zoratti EM, Kattan M, Grindle KA, Gern JE, Busse WW, Szefler SJ1 (2015). Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol, 136 (6), 1476-85.
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
(2015). Sci Transl Med, 7 (315), 315ra189. http://dx.doi.org/10.1126/scitranslmed.aad4134, PMID: 26606968, PMCID: PMC4729454
Bluestone JA, Buckner JH, Gitelman SE, Herold KC, Long SA, Rieck M, Sayre PH, Tang Q, Fitch M, Gupta S, Hellerstein MK, Lares A, Lee MR, Li K, Liu W, Masiello LM, Nguyen V, Putnam AL
[Reprint] [PubMed]
[Citation View]
Bluestone JA, Buckner JH, Gitelman SE, Herold KC, Long SA, Rieck M, Sayre PH, Tang Q, Fitch M, Gupta S, Hellerstein MK, Lares A, Lee MR, Li K, Liu W, Masiello LM, Nguyen V, Putnam AL (2015). Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci Transl Med, 7 (315), 315ra189.
T cell repertoire following autologous stem cell transplantation for multiple sclerosis
(2014). J Clin Invest, 124 (3), 1168-72. http://dx.doi.org/10.1172/JCI71691, PMID: 24531550, PMCID: PMC3934160
Muraro PA, Robins H, Malhotra S, Howell M, Phippard D, Desmarais C, de Paula Alves Sousa A, Griffith LM, Lim N, Nash RA, Turka LA
[Reprint] [PubMed]
[Citation View]
Muraro PA, Robins H, Malhotra S, Howell M, Phippard D, Desmarais C, de Paula Alves Sousa A, Griffith LM, Lim N, Nash RA, Turka LA (2014). T cell repertoire following autologous stem cell transplantation for multiple sclerosis . J Clin Invest, 124 (3), 1168-72.
High-throughput flow cytometry data normalization for clinical trials
(2014). Cytometry A, 85 (3), 277-86. http://dx.doi.org/10.1002/cyto.a.22433, PMID: 24382714, PMCID: PMC3992339
Finak G, Jiang W, Krouse K, Wei C, Sanz I, Phippard D, Asare D, De Rosa SC, Self S, Gottardo R
[Reprint] [PubMed]
[Citation View]
Finak G, Jiang W, Krouse K, Wei C, Sanz I, Phippard D, Asare D, De Rosa SC, Self S, Gottardo R (2014). High-throughput flow cytometry data normalization for clinical trials. Cytometry A, 85 (3), 277-86.
Rituximab for the Treatment of Relapses in antineutrophil cytoplasmic antibody-associated vasculitis
(2014). Arthritis Rheumatol, 66 (11), 3151-59. http://dx.doi.org/10.1002/art.38788, PMID: 25047592, PMCID: PMC4229846
Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St. Clair EW, Tchao NK, Viviano L, Ding L, Ikle D, Villareal M, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group
[Reprint] [PubMed]
[Citation View]
Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St. Clair EW, Tchao NK, Viviano L, Ding L, Ikle D, Villareal M, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group (2014). Rituximab for the Treatment of Relapses in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol, 66 (11), 3151-59.
Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
(2014). J Allergy Clin Immunol, 133 (2), 468-75. http://dx.doi.org/10.1016/j.jaci.2013.11.007, PMID: 24361082, PMCID: PMC3960331
Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW
[Reprint] [PubMed]
[Citation View]
Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW (2014). Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol, 133 (2), 468-75.
Development of cockroach immunotherapy by the Inner-City Asthma Consortium
(2014). J Allergy Clin Immunol, 133 (3), 846-52. http://dx.doi.org/10.1016/j.jaci.2013.08.047, PMID: 24184147, PMCID: PMC3943647
Wood RA, Togias A, Wildfire J, Visness CM, Matsui EC, Gruchalla R, Hershey G, Liu AH, O’Connor GT, Pongracic JA, Zoratti E, Little F, Granada M, Kennedy S, Durham SR, Shamji MH, Busse WW.
[Reprint] [PubMed]
[Citation View]
Wood RA, Togias A, Wildfire J, Visness CM, Matsui EC, Gruchalla R, Hershey G, Liu AH, O’Connor GT, Pongracic JA, Zoratti E, Little F, Granada M, Kennedy S, Durham SR, Shamji MH, Busse WW. (2014). Development of cockroach immunotherapy by the Inner-City Asthma Consortium. J Allergy Clin Immunol, 133 (3), 846-52.
Magnitude and mechanisms of glucose counterregulation following islet transplantation in patients with type 1 diabetes suffering from severe hypoglycaemic episodes
(2014). Diabetologia, 57 (3), 623-32. http://dx.doi.org/10.1007/s00125-013-3120-9, PMID: 24305963
Ang M, Meyer C, Brendel MD, Bretzel RG, Linn T
[PubMed]
[Citation View]
Ang M, Meyer C, Brendel MD, Bretzel RG, Linn T (2014). Magnitude and mechanisms of glucose counterregulation following islet transplantation in patients with type 1 diabetes suffering from severe hypoglycaemic episodes. Diabetologia, 57 (3), 623-32.
Treatment of lupus nephritis with abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study
(2014). Arthritis & Rheumatology, 66 (11), 3096-104. http://dx.doi.org/10.1002/art.38790, PMID: 25403681, PMCID: PMC4528976
The ACCESS Trial Group
[Reprint] [PubMed]
[Citation View]
The ACCESS Trial Group (2014). Treatment of lupus nephritis with abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study. Arthritis & Rheumatology, 66 (11), 3096-104.
Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression
(2014). Am J Transplant, 14 (7), 1599-1611. http://dx.doi.org/10.1111/ajt.12731, PMID: 24903438, PMCID: PMC4228952
Kawai T, Sachs DH, Sprangers B, Spitzer TR, Saidman Sl, Zorn E, Tolkoff-Rubin N, Preffer F, Crisalli K, Gao B, Wong W, Morris H, LoCascio SA, Sayre P, Shonts B, Williams WW, Colvin RB, Smith R-N, Sykes M, Cosimi AB.
[Reprint] [PubMed]
[Citation View]
Kawai T, Sachs DH, Sprangers B, Spitzer TR, Saidman Sl, Zorn E, Tolkoff-Rubin N, Preffer F, Crisalli K, Gao B, Wong W, Morris H, LoCascio SA, Sayre P, Shonts B, Williams WW, Colvin RB, Smith R-N, Sykes M, Cosimi AB. (2014). Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. Am J Transplant, 14 (7), 1599-1611.
Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: Immunologic effects and efficacy in NOD mice
(2013). PLoS One, 8 (2), e54712. http://dx.doi.org/10.1371/journal.pone.0054712, PMID: 23405091, PMCID: PMC3566105
Sarikonda G, Sachithanantham S, Manenkova Y, Kupfer T, Posgai A, Wasserfall C, Bernstein P, Straub L, Pagni PP, Schneider D, Calvo TR, Coulombe M, Herold K, Gill RG, Atkinson M, Nepom G, Ehlers M, Staeva T, Garren H, Steinman L, Chan AC, von Herrath M
[Reprint] [PubMed]
[Citation View]
Sarikonda G, Sachithanantham S, Manenkova Y, Kupfer T, Posgai A, Wasserfall C, Bernstein P, Straub L, Pagni PP, Schneider D, Calvo TR, Coulombe M, Herold K, Gill RG, Atkinson M, Nepom G, Ehlers M, Staeva T, Garren H, Steinman L, Chan AC, von Herrath M (2013). Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: Immunologic effects and efficacy in NOD mice. PLoS One, 8 (2), e54712.
Estimating the ratio of CD4+ to CD8+ T cells using high-throughput sequence data
(2013). J Immunol Methods, 391 (1-2), 14-21. http://dx.doi.org/10.1016/j.jim.2013.02.002, PMID: 23428915
Emerson R, Sherwood A, Desmarais C, Malhotra S, Phippard D, Robins H
[Reprint] [PubMed]
[Citation View]
Emerson R, Sherwood A, Desmarais C, Malhotra S, Phippard D, Robins H (2013). Estimating the ratio of CD4+ to CD8+ T cells using high-throughput sequence data. J Immunol Methods, 391 (1-2), 14-21.
Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: Metabolic and immunologic features at baseline identify a subgroup of responders
(2013). Diabetes, 62 (11), 3766-74. http://dx.doi.org/10.2337/db13-0345, PMID: 23835333, PMCID: PMC3806618
Herold KC, Gitelman SE, Ehlers MR, Gottlieb PA, Greenbaum CJ, Hagopian W, Boyle KD, Keyes-Elstein L, Aggarwal S, Phippard D, Sayre PH, McNamara J, Bluestone JA, the AbATE Study Team
[Reprint] [PubMed]
[Citation View]
Herold KC, Gitelman SE, Ehlers MR, Gottlieb PA, Greenbaum CJ, Hagopian W, Boyle KD, Keyes-Elstein L, Aggarwal S, Phippard D, Sayre PH, McNamara J, Bluestone JA, the AbATE Study Team (2013). Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: Metabolic and immunologic features at baseline identify a subgroup of responders. Diabetes, 62 (11), 3766-74.
Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
(2013). N Engl J Med, 369 (5), 417-27. http://dx.doi.org/10.1056/NEJMoa1213277, PMID: 23902481
Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CGM, St. Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH for the RAVE-ITN Research Group
[Reprint] [PubMed]
[Citation View]
Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CGM, St. Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH for the RAVE-ITN Research Group (2013). Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis. N Engl J Med, 369 (5), 417-27.